Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

MSD, Novo Nordisk On Accessing Korea’s Innovative Momentum

This article was originally published in PharmAsia News

Executive Summary

At a recent biotech convention in Seoul, MSD and Novo Nordisk talked were both bullish on accessing innovation in Asia-Pacific, with the US firm in particular stepping up its business development and licensing activities in South Korea to access what it sees as the innovative momentum in the country.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register